(Q39493615)

12 September 2017

title

As(2)O (3) oxidation by vitamin C: cell culture studies (English)

1 reference

12 September 2017

0 references

Andreja Zelenik Pevec

1

1 reference

12 September 2017

Zdenka Slejkovec

2

1 reference

12 September 2017

Johannes T van Elteren

3

1 reference

12 September 2017

Ingrid Falnoga

4

1 reference

12 September 2017

publication date

7 August 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

25

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

103-113

1 reference

Arsenic toxicology: five questions

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Metabolism and the paradoxical effects of arsenic: carcinogenesis and anticancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Stress proteins induced by arsenic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Arsenical-based cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Investigation of the role of extracellular H2O2 and transition metal ions in the genotoxic action of ascorbic acid in cell culture models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Arsenic metabolism in multiple myeloma and astrocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Light-dependent generation of reactive oxygen species in cell culture media

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Thioredoxin and thioredoxin reductase: current research with special reference to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Vitamin C protects HL60 and U266 cells from arsenic toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Total anti-oxidant capacity of cell culture media

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Redox-directed cancer therapeutics: molecular mechanisms and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9486-6

10.1007/S10534-011-9486-6

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference